Y52-22884-48843 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-13
Registered in v-safe
2021-01-13
Dose 1 — Pfizer-BioNTech
2021-01-13
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-15
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness, Palpitations — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Dizziness and heart racing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Joint pains, Muscle or body aches

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-22
Health check-in — day 7, dose 1
Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-27
Survey response — day 14, dose 1
MedDRA: Blister, Genital infection, Headache, Injection site pain, Myalgia, Pelvic infection, Pyrexia, Rash, Unevaluable event — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Symptoms: Very sore at injection site, muscle pain in arms, fevers, severe rash on hands & fingers- blisters- infection in private areas, headaches all have gradually worsened- · Healthcare visit (other): Some not addressed by health care providers yet

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-27
Report sent to call center — day 14, dose 1
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-03
Dose 2 — Pfizer-BioNTech
2021-02-25
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-03
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-10
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-03-17
Health check-in — day 42, dose 2
Feeling: Poor

Adult check-in
2021-05-05
Survey response — 3 months, dose 2
MedDRA: Dyspnoea, Pyrexia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Unexplainable high fevers of up to 102.8Labored breathing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-08
Call successful
Does not wish to fill out VAERS report
2021-08-06
Survey response — 6 months, dose 2
MedDRA: Dyspnoea — Feeling: Fair

Free text: Breathing on an ongoing basis is more difficult

MedDRA releases: 2021-09,2024-11 · check-in free text available
2022-02-06
Survey response — 12 months, dose 2
MedDRA: Laboratory test abnormal, Malaise, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Symptoms: I tested positive and was very ill · Healthcare visit (other): In person with my primary

MedDRA releases: 2024-11 · check-in free text available
2022-02-06
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-07
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-13	Pfizer-BioNTech
2	2021-02-03	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-27	Successful 2021-06-08	Does not wish to fill out VAERS report
2022-02-06	Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-15

Systemic reaction (other): Dizziness and heart racing

Release 2 — day 14, dose 1

2021-01-27

Symptoms: Very sore at injection site, muscle pain in arms, fevers, severe rash on hands & fingers- blisters- infection in private areas, headaches all have gradually worsened-

Healthcare visit (other): Some not addressed by health care providers yet

Release 8 — 3 months, dose 2

2021-05-05

Symptoms: Unexplainable high fevers of up to 102.8Labored breathing

Release 9 — 6 months, dose 2

2021-08-06

Symptoms: Breathing on an ongoing basis is more difficult

Release 11 — 12 months, dose 2

2022-02-06

Symptoms: I tested positive and was very ill

Healthcare visit (other): In person with my primary

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
HCVO	Unevaluable event	✓	✓	✓
SD	Blister	✓	✓	✓
SD	Dyspnoea	✓	✓	✓
SD	Genital infection	✓	·	✓
SD	Headache	✓	✓	✓
SD	Injection site pain	✓	✓	✓
SD	Laboratory test abnormal	·	·	✓
SD	Malaise	·	·	✓
SD	Myalgia	✓	✓	✓
SD	Pelvic infection	○	✓	○
SD	Pyrexia	✓	✓	✓
SD	Rash	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Palpitations	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release